Lamas, C., Cámara, R., Fajardo, C., Remon-Ruiz, P., Biagetti, B., Guerrero-Pérez, F., . . . Soto, A. (2023). Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain.
Citación estilo ChicagoLamas, C., et al. Efficacy and Safety of Temozolomide in the Treatment of Aggressive Pituitary Neuroendocrine Tumours in Spain. 2023.
Cita MLALamas, C., et al. Efficacy and Safety of Temozolomide in the Treatment of Aggressive Pituitary Neuroendocrine Tumours in Spain. 2023.
Precaución: Estas citas no son 100% exactas.